États-Unis · Magazines éco · Quartz

Merck topped estimates and raised its profit forecast as cancer drug injection took off

Publié par Quartz · États-Unis il y a 1 h

Adjusted profit forecast moves to $2.77 to $2.82 a share from $2.66 to $2.76 as Keytruda Qlex sales reach $830 million

Lire l'article complet sur Quartz Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (qz.com)

À lire aussi

Halloween Reveals a Scary Mistake Even Smart Entrepreneurs Make

ECB’s president Christine Lagarde is resigning nine months early, giving EU leaders a chance to pick a successor before France’s elections

Your Adjustable-Rate Mortgage Is About to Reset. Here Are 5 Moves to Make Now

Purple is everywhere in fintech. This bank rebranded but kept the color

DoorDash strikes $17B deal for rival Instacart in bets on grocery delivery

D.C.'s foie gras ban could face a costly court fight